Previously, Rac1 has been shown to have high expression in different types of tumors, which was associated with poor prognosis, and its high expression in NSCLC stem cells enhanced the malignant behavior of tumor cells [4, 17]. Here, RAC1 is linked to non-small cell lung carcinoma.